Clinical prevention of breast and prostate cancers.

被引：0
|
作者：
Greenwald, P [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1953S / 1953S
页数：1
相关论文
共 50 条
  • [41] Tumors and Cancers.
    Blacker, C. P.
    EUGENICS REVIEW, 1929, 20 (04): : 280 - 280
  • [42] Toremifene and breast cancer therapy: incidence of secondary endometrial cancers.
    Erkkola, R
    Nevala, P
    Mantyla, E
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156
  • [43] Development and testing of a polygenic risk score for proliferative breast cancers.
    Shieh, Yiwey
    Roger, Jacquelyn
    Huntsman, Scott
    Hu, Donglei
    Nierenberg, Jovia L.
    Kapoor, Pooja Middha
    Yau, Christina
    Hirst, Gillian
    van 't Veer, Laura
    Esserman, Laura
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Value in breast and prostate cancers
    Ferreira, Pedro L.
    Sequeira, Teresa
    Silveira, Augusta
    Ferreira, Lara
    Quintal, Carlota
    Goncalves, Suzete
    Carvalho, Lurdes
    Teixeira, Joana
    Eberhardt, Ana
    QUALITY OF LIFE RESEARCH, 2015, 24 : 135 - 135
  • [45] Cyclooxygenase-2 is frequently overexpressed in human breast cancers.
    Half, EE
    Barnes, CJ
    Chiang, E
    Sneige, N
    Sahin, AA
    Sinicrope, FA
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 296 - 296
  • [46] Reasons for mastectomy as surgery of choice for women with small breast cancers.
    Whannel, K. J.
    George, D. W.
    Wilson, C. R.
    Doughty, J. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S119 - S119
  • [47] Profiling receptor tyrosine kinase fusions in Chinese breast cancers.
    Tao, Zhonghua
    Hu, Xichun
    Cao, Wen-Ming
    Liu, Jianxia
    Li, Ting
    Xu, Hong
    Chen, Kai
    Zhang, Jian
    Zhou, Hao
    Sun, Jie
    Han, Jinming
    Yang, Hua
    Shao, Lin
    Xiang, Jianxing
    Guan, Xiaoqian
    Li, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Statins decrease levels of the estrogen receptor in human breast cancers.
    Hohl, RJ
    Roman, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P45 - P45
  • [49] Mass spectrometry and DNA chemistry: Applications in breast and skin cancers.
    Gross, ML
    Ramanathan, R
    Wan, K
    Taylor, JT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U97 - U97
  • [50] Molecular comparison of interval and screen-detected breast cancers.
    Cheasley, Dane Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345